1-11 of 11
Barbara A. Conley
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract CT160: BVD-523FB (Ulixertinib) in Patients with Tumors with BRAF Fusions, or with Non-V600E, Non-V600K BRAF Mutations: Results from the NCI-MATCH ECOG-ACRIN Trial (EAY131) Sub-protocol EAY131-Z1L

Vivek Subbiah, Fengmin Fengmin, Ragini Kudchadkar, Ryan J. Sullivan, Edith P. Mitchell, John J. Wright, Helen X. Chen, Robert J. Gray, Xin Victoria Wang, Lisa M. McShane, Larry V. Rubinstein, David Patton, P. Mickey Williams, Tilak K. Sundaresan, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O'Dwyer, Alice P. Chen, Keith T. Flaherty
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): CT160.
DOI: https://doi.org/10.1158/1538-7445.AM2022-CT160
Published: 15 June 2022
View article
Journal Articles

Abstract CT139: NCI Molecular Analysis for Therapy Choice (NCI-MATCH EAY131) arm B: Phase II study of afatinib in patients (pts) with HER2 (ERBB2) activating mutations

Philippe L. Bedard, Shuli Li, Kari B. Wisinski, Eddy S. Yang, Sewanti A. Limaye, Edith P. Mitchell, James A. Zwiebel, Jeffrey Moscow, Robert J. Gray, Lisa M. McShane, Larry V. Rubenstein, David R. Patton, P Mickey Williams, Stanley R. Hamilton, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O'Dwyer, Alice P. Chen, Keith T. Flaherty
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT139.
DOI: https://doi.org/10.1158/1538-7445.AM2019-CT139
Published: 01 July 2019
View article
Journal Articles

Abstract CT138: NCI-MATCH EAY131 -Z1I: Phase II study of AZD1775, a wee-1 kinase inhibitor, in patients with tumors containing BRCA1 and BRCA2 mutations

Shivaani Kummar, Shuli Li, Kim Reiss, James M. Ford, Edith P. Mitchell, James A. Zwiebel, Naoko Takebe, Robert J. Gray, Lisa M. McShane, Larry V. Rubinstein, David Patton, Paul Mickey Williams, Stanley R. Hamilton, Adam Brufsky, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O'Dwyer, Alice P. Chen, Keith T. Flaherty
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): CT138.
DOI: https://doi.org/10.1158/1538-7445.AM2019-CT138
Published: 01 July 2019
View article
Journal Articles

Abstract LB-010: Molecular analysis for therapy choice (NCI-MATCH, EAY131) arm Z1B: Phase II trial of palbociclib for CCND1, 2 or 3 amplified tumors

Amy S. Clark, Fangxin Hong, Richard S. Finn, Angela M. DeMichele, Edith P. Mitchell, James Zweibel, Fernanda I. Arnaldez, Lisa M. McShane, Shuli Li, Robert J. Gray, Larry V. Rubenstein, David Patton, P Mickey Williams, Stanley R. Hamilton, Mehmet S. Copur, Sameer S. Kasbari, Ravneet Thind, Barbara A. Conley, Peter J. O'Dwyer, Lyndsay N. Harris, Carlos L. Arteaga, Alice P. Chen, Keith T. Flaherty
Journal: Cancer Research
Cancer Res (2019) 79 (13_Supplement): LB-010.
DOI: https://doi.org/10.1158/1538-7445.AM2019-LB-010
Published: 01 July 2019
View article
Journal Articles

Abstract CT101: NCI-molecular analysis for therapy choice (NCI-MATCH) clinical trial: interim analysis

Barbara A. Conley, Robert Gray, Alice Chen, Peter O’Dwyer, Carlos Arteaga, Brent Coffey, David Patton, Shuli Li, Lisa M. McShane, Larry Rubinstein, Robert Comis, Jeffrey Abrams, Paul M. Williams, Chih-Jian Lih, Stanley Hamilton, Edith Mitchell, James Zwiebel, Keith Flaherty, NCI MATCH team
Journal: Cancer Research
Cancer Res (2016) 76 (14_Supplement): CT101.
DOI: https://doi.org/10.1158/1538-7445.AM2016-CT101
Published: 15 July 2016
View article
Journal Articles

Abstract 612: The NCI exceptional responders initiatives: Initial feasibility result

Barbara A. Conley, S Percy Ivy, James V. Tricoli, Jean-Claude Zenklusen, Roy Tarnuzzer, Irina Lubensky, Naoko Takebe, Paul M. Williams, JoAnne Zujewski, Richard Little, Jeffrey White, Elise Kohn, Shakun Malik, Ben Kim, Erin Souhan, Lou Staudt
Journal: Cancer Research
Cancer Res (2015) 75 (15_Supplement): 612.
DOI: https://doi.org/10.1158/1538-7445.AM2015-612
Published: 01 August 2015
View article
Journal Articles

Endoglin Regulates Cancer–Stromal Cell Interactions in Prostate Tumors

Diana Romero, Christine O'Neill, Aleksandra Terzic, Liangru Contois, Kira Young, Barbara A. Conley, Raymond C. Bergan, Peter C. Brooks, Calvin P.H. Vary
Journal: Cancer Research
Cancer Res (2011) 71 (10): 3482–3493.
DOI: https://doi.org/10.1158/0008-5472.CAN-10-2665
Published: 15 May 2011
View article
PDF
Includes: Supplementary data
Journal Articles

Abstract 1657: HSP90 inhibition down regulates EGFR and its effector signaling proteins in pancreatic cancer cell lines

Sreenivasa R. Chandana, Cheryl Leece, Manisha Bhutani, Barbara A. Conley
Journal: Cancer Research
Cancer Res (2010) 70 (8_Supplement): 1657.
DOI: https://doi.org/10.1158/1538-7445.AM10-1657
Published: 15 April 2010
View article
Journal Articles

Interspecies differences in plasma protein binding of MS-275, a novel histone deacetylase inhibitor

Milin R. Acharya, Alex Sparreboom, Edward A. Sausville, Barbara A. Conley, James H. Doroshow, Jurgen Venitz, William D. Figg
Journal: Cancer Research
Cancer Res (2005) 65 (9_Supplement): 983.
Published: 01 May 2005
View article
Journal Articles

Phase I Trial Using Adaptive Control Dosing of Hexamethylene Bisacetamide (NSC 95580)

Barbara A. Conley, Alan Forrest, Merrill J. Egorin, Eleanor G. Zuhowski, Victoria Sinibaldi, David A. Van Echo
Journal: Cancer Research
Cancer Res (1989) 49 (12): 3436–3440.
Published: 01 June 1989
View article
PDF
Journal Articles

Phase I Study and Pharmacokinetics of Menogaril (NSC 269148) in Patients with Hepatic Dysfunction

Merrill J. Egorin, Barbara A. Conley, Alan Forrest, Eleanor G. Zuhowski, Vickie Sinibaldi, David A. Van Echo
Journal: Cancer Research
Cancer Res (1987) 47 (22): 6104–6110.
Published: 01 November 1987
View article
PDF